Nevia bio

Company Overview

Snapshot

Founded in January 2020 by Inbal Zafir-Lavie, Shlomit Yehudai-Resheff, and Roni Michaely, Nevia bio operates with 11–50 employees. The company has raised $5M across three funding rounds. In August 2023, Nevia bio completed a Seed round to advance its machine learning-enabled platform for early detection of women-related diseases.

Business overview

Nevia bio is an innovative health technology company focused on transforming women's health through the discovery of biomarkers in vaginal fluid. The company develops non-invasive, AI-driven diagnostic solutions for the early detection of gynecological cancers, with an initial focus on ovarian cancer. By leveraging a large database of vaginal fluid and multi-omics data, Nevia bio aims to pioneer a breakthrough diagnostic platform to detect cancers at their earliest stages, thereby improving patient outcomes and reducing treatment costs. The company operates within the Health Tech & Life Sciences sector, specifically in Test Diagnostics & Screening, Digital Healthcare, and Medical Devices.

Strategic signal

In August 2023, Nevia bio completed a Seed funding round to build a machine learning-enabled platform for the early detection of women-related diseases. This investment signals strong investor confidence in the company's AI-driven approach to address critical gaps in women's health diagnostics, particularly for conditions like ovarian cancer, and positions Nevia bio for accelerated development and market entry.

Company Intelligence Q&A

When was Nevia bio founded?

Nevia bio was founded in January 2020.

Who are the founders of Nevia bio?

Nevia bio was founded by Inbal Zafir-Lavie, Shlomit Yehudai-Resheff, and Roni Michaely.

What is Nevia bio's primary focus?

Nevia bio focuses on developing non-invasive, AI-driven diagnostic solutions for the early detection of gynecological cancers, with an initial emphasis on ovarian cancer, by analyzing biomarkers in vaginal fluid.

What was a significant funding event for Nevia bio?

In August 2023, Nevia bio completed a Seed round to build a machine learning-enabled platform for the early detection of women-related diseases. MindUP was a lead investor in this round.

What technology does Nevia bio leverage for its diagnostic platform?

Nevia bio leverages artificial intelligence and machine learning, utilizing a large database of vaginal fluid and multi-omics data to develop its diagnostic platform.